Abbreviations and Acronyms
Disclaimer
Preface
1 Overview
   1.1 Definition of Electroceuticals
   1.2 Electroceuticals vs. Digital Therapeutics
   1.3 Scope of Research

2 Understanding Electroceuticals Technology
   2.1 Understanding TMS
      2.1.1 Clinical Evidence Development
      2.1.2 Treatment Process of rTMS
      2.1.3 Latest Technology Trends
   2.2 Understanding tDCS
      2.2.1 Clinical Evidence Development
      2.2.2 Treatment Process of tDCS

3 Current Market of Electroceuticals
   3.1 Current Market of Korea
      3.1.1 Major Suppliers
      3.1.2 Electroceuticals and NHIS
      3.1.3 Clinical Trials Approved in Korea
   3.2 Global Electroceuticals Market
      3.2.1 Major Suppliers
      3.2.2 Global Clinical Trials on Electroceuticals
      3.2.3 Global Electroceuticals Research & Development

4 Demand Forecast for Electroceuticals
   4.1 Electroceuticals by Indication
      4.1.1 Depression
      4.1.2 Anxiety Disorder
      4.1.3 Insomnia
      4.1.4 Obsessive-Compulsive Disorder
      4.1.5 Addiction
   4.2 Market Size of Pharmaceuticals to Electroceuticals’ Indications
   4.3 Market Drivers and Market Restraints
      4.3.1 Market Drivers
      4.3.2 Market Restraints

5 Business Strategy Suggestions
   5.1 Korean Market Access Strategy
   5.2 Global Market Access Strategy
   5.3 Conclusion

Appendix 1 Detailed Target Disease Codes
Appendix 2 Non-Reimbursement TMS Charges
Appendix 3 TMS Device FDA Approval Status

Table 1 Therapeutic Classification by Generation
Table 2 Electroceuticals vs. Digital Therapeutics
Table 3 Major Non-Invasive Stimulation Methods
Table 4 Electroceuricals already launched & to-be-launched in Korea
Table 5 Remed Product Approvals
Table 6 Current Businesses of Remed
Table 7 Ybrain Product Approvals
Table 8 Top 5 Non-Reimbursement TMS Fees
Table 9 Notifications on TMS-related nHTA Suspension
Table 10 Major Clinical Trials on TMS in Korea
Table 11 Major Clinical Trials on tDCS in Korea
Table 12 Global Clinical Trials on rTMS
Table 13 Global Clinical Trials on tDCS
Table 14 Cochrane and NICE Studies on TMS (including rTMS)
Table 15 Cochrane and NICE Studies on tDCS
Table 16 Five-Year Forecast of Electroceuticals Indications
Table 17 Number of Claims for Depression 2017-2021
Table 18 Five-Year Forecast of Depression Market 2021-2025
Table 19 Number of Claims for Anxiety Disorder 2017-2021
Table 20 Five-Year Forecast of Anxiety Disorder Market 2021-2025
Table 21 Number of Claims for Insomnia 2017-2021
Table 22 Five-Year Forecast of Insomnia Market 2021-2025
Table 23 Number of Claims for Obsessive-Compulsive Disorder 2017-2021
Table 24 Five-Year Forecast of OCD Market 2021-2025
Table 25 Number of Claims for Addiction 2017-2021
Table 26 Number of Claims for Addiction on Gambling 2017-2021
Table 27 Market Size of Drugs to Electroceuticals’ Indications 2018-2022
Table 28 List of Approved Drugs to Electroceuticals’ Indications
Table 29 Documents to be submitted (Article 28, Rules on Medical Device Approval, Notification & Review)
Table 30 Possible Specialties of Primary Care Institutions
Table 31 FDA Product Codes for TMS

Figure 1 Types of Electroceuticals
Figure 2 DFPFC and VMPFC inside Brain
Figure 3 rTMS Treatment Mechanism
Figure 4 tDCS Treatment Mechanism
Figure 5 ALTMS Product Image
Figure 6 Minddstim product image
Figure 7 Class Ⅱ Approval Process
Figure 8 Class Ⅲ & Class Ⅳ Approval Process
Figure 9 MFDS Approval Process of Clinical Trial Protocol
Figure 10 Exclusions and procedures for MFDS IND approval

Remed
NuEyne
Ybrain
Neurophet
Brainsway
Neuronetics
Magstim
Magventure